BenzingaAugust 18, 2026 at 5:47 AM NY2 Months Ago
BTIG Reiterates Buy on Medtronic, Maintains $91 Price Target
BTIG analyst Ryan Zimmerman reiterates Medtronic (NYSE:MDT) with a Buy and maintains $91 price target.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
